Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1318 of 5804
-
Kids with gut or joint inflammation get long-term safety check on biologic drug guselkumab
Disease control Recruiting nowThe purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative colitis, or moderately to severely active Crohn's disease, or juvenile psoriatic arthritis (jPsA).
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a lower starting dose help older breast cancer patients stick with treatment?
Knowledge-focused Recruiting nowThe purpose of this study is to generate evidence on an alternative dosing strategy for CDK4/6 inhibitors to help more patients with Metastatic Breast Cancer (MBC) (age ≥ 65 years) tolerate side effects and stay on treatment longer, to derive the most clinical benefit from these …
Phase: PHASE3 • Sponsor: American Society of Clinical Oncology • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Heat and radiation boost chemoimmunotherapy in bile duct cancer trial
Disease control Recruiting nowThis study is being done to see if the investigators can improve the outcome of patients with biliary tract cancer that do not qualify for surgery. This study will compare the effects, good and/or bad, of using a combination of standard of care chemoimmunotherapy, with the additi…
Phase: PHASE1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a blood pressure drug combo tame panic attacks?
Disease control TerminatedThe purpose of this study is to determine the safety and efficacy of HB-1, versus placebo and two monotherapies, in male and female adult patients aged 18 to 65 years, inclusive, with Panic Disorder.
Phase: PHASE2 • Sponsor: HB BioTech, LLC • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New rectal gel could offer On-Demand HIV protection without daily pills
Prevention CompletedThis is a Phase 2, multi-site, two-period, open label randomized crossover (Period 1 and 2) study. Participants are randomized 1:1 to one of two 8-week on-demand product sequences - TFV douche then oral F/TDF or oral F/TDF then TFV douche - with a 2 to 4-week washout period in be…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
New inhaled drug aims to ease lung scarring and heart strain
Disease control OngoingThis is a Phase 2, randomized, double-blind, placebo-controlled, multi-center clinical study to evaluate the safety and efficacy of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Phase: PHASE2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can Omega-3 and diet advice tame fatty liver disease?
Disease control CompletedThe aim of this clinical trial is to examine the impact of nutritional education and omega-3 supplementation in influencing body weight, liver enzyme levels, and lipid profiles in patients diagnosed with non-alcoholic fatty liver disease. Eligible patients who have non-alcoholic…
Phase: NA • Sponsor: Hawler Medical University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Can a 40 hz burst of sound silence tinnitus?
Symptom relief CompletedTinnitus affects 10-15% of adults and is frequently associated with impaired quality of life, anxiety, and sleep disturbance. Conventional sound therapies based on continuous masking provide inconsistent and short-lived relief, and the neural mechanisms underlying residual inhibi…
Phase: NA • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 26, 2026 16:47 UTC
-
Can a love hormone help veterans heal from PTSD?
Symptom relief Recruiting nowLeveraging veterans' intimate relationships during treatment for posttraumatic stress disorder (PTSD) has the potential to concurrently improve PTSD symptoms and relationship quality. Brief Cognitive-Behavioral Conjoint Therapy (bCBCT) is a manualized treatment designed to simult…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Amniotic membrane patch shows promise for stubborn diabetic wounds
Disease control OngoingThis trial is a multicenter, randomized, controlled study designed to evaluate the safety and efficacy of BioREtain® Amniotic Membrane (BR-AM) plus standard of care versus standard of care only in the treatment of diabetic foot ulcers. The trial design will control potential vari…
Phase: NA • Sponsor: BioStem Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New radiation technique offers hope for head and neck cancer patients with few options
Symptom relief Recruiting nowThis trial tests how well personalized ultra fractionated stereotactic adaptive radiotherapy (PULSAR) works together with HyperArc© radiation treatment planning technology for palliative (holistic pain and symptom control) tumor control in patients with primary or recurrent, loca…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New pill shows promise for psoriasis in early trial
Disease control CompletedThe main purpose of this study is to assess the safety and efficacy of LY4100511 in adult participants with moderate-to-severe plaque psoriasis.
Phase: PHASE2 • Sponsor: DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company • Aim: Disease control
Last updated Jun 26, 2026 15:32 UTC
-
Could a common mushroom help fight breast cancer? new trial investigates
Disease control Recruiting nowThis phase II trial tests how well turkey tail mushroom (TTM) works in treating post-menopausal women with HER2-negative, estrogen receptor (ER)-positive breast cancer undergoing surgery. TTM is a common mushroom. In traditional Chinese medicine, it is used for enhancing function…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for advanced breast cancer: first human trial of MEN2312 begins
Disease control Recruiting nowThis is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer.
Phase: PHASE1 • Sponsor: Stemline Therapeutics, Inc. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug LTP001 aims to ease rare lung condition
Disease control Recruiting nowA study to learn about the treatment LTP001 in healthy participants (Part A) and in participants with PAH (Part B)
Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could virtual reality help lungs heal faster after surgery?
Symptom relief CompletedThis study aims to investigate the effects of virtual reality-based exercise training after thoracic surgery. Participants undergoing lung resection surgery will be assigned to either a virtual reality exercise training group or a control group receiving standard care. Physical f…
Phase: NA • Sponsor: Pamukkale University • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New stomach drug may protect heart patients from dangerous bleeding
Prevention Recruiting nowThis study evaluates whether fexuprazan is effective in preventing upper gastrointestinal bleeding and related upper gastrointestinal clinical events in high bleeding risk patients who require dual antiplatelet therapy after coronary stent implantation. A total of 400 participan…
Phase: NA • Sponsor: SUK MIN SEO • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Off-the-Shelf CAR-T cells take on tough blood cancers
Disease control TerminatedThis study is a single-arm, single-center, investigator-initiated clinical trial. The primary objective is to evaluate the safety and preliminary efficacy of administering universal CD19 CAR-T cells to subjects with refractory and relapsed B-cell tumors. Eligible participants wil…
Phase: EARLY_PHASE1 • Sponsor: Wondercel Biotech (ShenZhen) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug HY07121 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis is a multi-center, open-label, phase 1/2 study to evaluate the safety, efficacy, and pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of HY07121 in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Sichuan Huiyu Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Promising new drug targets genetic Parkinson's in early trial
Disease control OngoingThis Phase 2a, multicenter, randomized, 12-week double-blind, placebo-controlled, parallel-group study, followed by an OLE, is designed to evaluate the safety, tolerability, and pharmacodynamic effects of BIIB122 in participants with LRRK2-PD. LRRK2-PD is defined as Parkinson's D…
Phase: PHASE2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC